These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 8354766

  • 1. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1993 Jun; 28(2):105-16. PubMed ID: 8354766
    [Abstract] [Full Text] [Related]

  • 2. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
    Dierick M, Cattiez P, Franck G, Burton P, Defleur J, Hermans W, Roelandts A, Wolfrum C, Berger M, Hellstern K.
    Acta Psychiatr Scand Suppl; 1990 Jun; 360():50-1. PubMed ID: 2248071
    [Abstract] [Full Text] [Related]

  • 3. Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.
    Larsen JK, Holm P, Mikkelsen PL.
    Acta Psychiatr Scand; 1984 Sep; 70(3):254-60. PubMed ID: 6388247
    [Abstract] [Full Text] [Related]

  • 4. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
    Civeira J, Cervera S, Giner J, Allen SR, Hellstern K, Malanowski H, Wirz R, Klar K.
    Acta Psychiatr Scand Suppl; 1990 Sep; 360():48-9. PubMed ID: 2248070
    [Abstract] [Full Text] [Related]

  • 5. Plasma amino acid profiles in relation to clinical response to moclobemide in patients with major depression. Danish University Antidepressant Group.
    Møller SE.
    J Affect Disord; 1993 Apr; 27(4):225-31. PubMed ID: 8509523
    [Abstract] [Full Text] [Related]

  • 6. Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
    Guelfi JD, Payan C, Fermanian J, Pedarriosse AM, Manfredi R.
    Br J Psychiatry; 1992 Apr; 160():519-24. PubMed ID: 1571752
    [Abstract] [Full Text] [Related]

  • 7. Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression. A Study group.
    Lecrubier Y, Pedarriosse AM, Payan C, Schmid-Burgk W, Stabl M.
    Acta Psychiatr Scand; 1995 Oct; 92(4):260-5. PubMed ID: 8848950
    [Abstract] [Full Text] [Related]

  • 8. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
    Funke HJ, Moritz E, Hellstern K, Malanowski H.
    Acta Psychiatr Scand Suppl; 1990 Oct; 360():46-7. PubMed ID: 2248069
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. RIMA--a new concept in the treatment of depression with moclobemide.
    Amrein R, Hetzel W, Stabl M, Schmid-Burgk W.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
    [Abstract] [Full Text] [Related]

  • 12. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
    Dingemanse J, Kneer J, Fotteler B, Groen H, Peeters PA, Jonkman JH.
    J Clin Psychopharmacol; 1995 Feb; 15(1):41-8. PubMed ID: 7714227
    [Abstract] [Full Text] [Related]

  • 13. Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study.
    Kragh-Sørensen P, Müller B, Andersen JV, Buch D, Stage KB.
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):24S-30S. PubMed ID: 7593726
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Moclobemide--placebo-controlled trials.
    Silverstone T.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):133-6. PubMed ID: 8468433
    [Abstract] [Full Text] [Related]

  • 17. The Major Depression Rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trials. Danish University Antidepressant Group.
    Bech P, Stage KB, Nair NP, Larsen JK, Kragh-Sørensen P, Gjerris A.
    J Affect Disord; 1997 Jan; 42(1):39-48. PubMed ID: 9089057
    [Abstract] [Full Text] [Related]

  • 18. The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.
    Krüger MB, Dahl AA.
    Eur Arch Psychiatry Clin Neurosci; 1999 Jan; 249 Suppl 1():S19-24. PubMed ID: 10361962
    [Abstract] [Full Text] [Related]

  • 19. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1990 Apr; 18(4):289-99. PubMed ID: 2140382
    [Abstract] [Full Text] [Related]

  • 20. Moclobemide and clomipramine in endogenous depression. A randomized clinical trial.
    Koczkas C, Holm P, Karlsson A, Nagy A, Ose E, Pétursson H, Ulverås L, Wenedikter O.
    Acta Psychiatr Scand; 1989 Jun; 79(6):523-9. PubMed ID: 2669440
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.